{"registry_intelligence":{"schema_version":"alpha-registry-intelligence-v1","record_version":"unavailable","subject":"alpha:company:ultragenyx-pharmaceutical-inc","as_of":"unavailable","recorded_at":"unavailable","availability":"unavailable","records":[],"next_offset":null,"limitations":["Structured intelligence is not currently available. Existing published profile evidence remains accessible."]},"protocol_version":"0.1","schema_version":"alpha.governance.entity.public.v1","record_version":"public-1","entity":{"id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","type":"Company","slug":"ultragenyx-pharmaceutical-inc","canonical_url":"https://registry.alpha.ac/companies/ultragenyx-pharmaceutical-inc","legal_name":"Ultragenyx Pharmaceutical Inc.","display_name":"Ultragenyx Pharmaceutical Inc.","aliases":[]},"publication":{"state":"PUBLISHED","published_at":"2026-09-28T14:40:03.785268+00:00","observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":"2026-09-28T14:40:03.785268+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":22,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/ultragenyx-pharmaceutical-inc","media_type":"text/html"},"markdown":{"href":"https://registry.alpha.ac/companies/ultragenyx-pharmaceutical-inc.md","media_type":"text/markdown"},"json":{"href":"https://registry.alpha.ac/api/public/companies/ultragenyx-pharmaceutical-inc?format=record","media_type":"application/json"},"jsonld":{"href":"https://registry.alpha.ac/api/public/companies/ultragenyx-pharmaceutical-inc?format=jsonld","media_type":"application/ld+json"},"api":{"href":"https://registry.alpha.ac/api/public/companies/ultragenyx-pharmaceutical-inc","media_type":"application/json"},"mcp":{"uri":"alpha://companies/ultragenyx-pharmaceutical-inc","endpoint":"https://mcp.alpha.ac/mcp","media_type":"application/json"}},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":22,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":22,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":22,"corroborated_claims":0,"sources":3,"distinct_sources":2,"role_claims":0,"last_reviewed_at":"2026-09-28T14:40:03.785268+00:00","observed_at":"2026-09-28T14:40:03.785268+00:00","freshness_days":0}},"claims":[{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:legal_name:1","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"schema:legalName","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Ultragenyx Pharmaceutical Inc.","claim_type":"legal_name","predicate_id":"alpha:predicate:legal_name","predicate_version":1,"machine_key":"legal_name","human_label":"Legal Name","governed_predicate":true,"machine_value":"Ultragenyx Pharmaceutical Inc.","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/ultragenyx-pharmaceutical-inc","source_date":null,"retrieved_at":"2026-09-28T14:40:03.785268+00:00","locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:entity_status:3","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:entityStatus","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Public listing published","claim_type":"entity_status","predicate_id":"alpha:predicate:entity_status","predicate_version":1,"machine_key":"entity_status","human_label":"Entity Status","governed_predicate":true,"machine_value":"Public listing published","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/ultragenyx-pharmaceutical-inc","source_date":null,"retrieved_at":"2026-09-28T14:40:03.785268+00:00","locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:published_fact:4","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:country","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"US","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"US","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/ultragenyx-pharmaceutical-inc","source_date":null,"retrieved_at":"2026-09-28T14:40:03.785268+00:00","locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:5","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:daniel-g-welch-rare","object_label":null,"object_source_name_forms":[],"value":"Daniel G. Welch: Independent Chairman of the Board","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Daniel G. Welch: Independent Chairman of the Board","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000174","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-12T18:07:23.013453+00:00","locator":null}],"source_date":"2026-03-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:6","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:amrit-ray-rare","object_label":null,"object_source_name_forms":[],"value":"Amrit Ray: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Amrit Ray: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:3","source_type":"sec_proxy","title":"DEF 14A lrare2026_def14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-02T01:57:54.019734+00:00","locator":null}],"source_date":"2026-03-27T00:00:00+00:00","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:7","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:amrit-ray-m-d","object_label":null,"object_source_name_forms":[],"value":"Amrit Ray, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Amrit Ray, M.D.: Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000174","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-12T18:07:23.013453+00:00","locator":null}],"source_date":"2026-03-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:8","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:corsee-d-sanders-rare","object_label":null,"object_source_name_forms":[],"value":"Corsee D. Sanders: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Corsee D. Sanders: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:3","source_type":"sec_proxy","title":"DEF 14A lrare2026_def14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-02T01:57:54.019734+00:00","locator":null}],"source_date":"2026-03-27T00:00:00+00:00","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:9","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:corsee-d-sanders-ph-d","object_label":null,"object_source_name_forms":[],"value":"Corsee D. Sanders, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Corsee D. Sanders, Ph.D.: Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000174","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-12T18:07:23.013453+00:00","locator":null}],"source_date":"2026-03-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:10","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:deborah-dunsire-rare","object_label":null,"object_source_name_forms":[],"value":"Deborah Dunsire: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Deborah Dunsire: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:3","source_type":"sec_proxy","title":"DEF 14A lrare2026_def14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-02T01:57:54.019734+00:00","locator":null}],"source_date":"2026-03-27T00:00:00+00:00","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:11","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:deborah-dunsire-m-d","object_label":null,"object_source_name_forms":[],"value":"Deborah Dunsire, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Deborah Dunsire, M.D.: Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000174","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-12T18:07:23.013453+00:00","locator":null}],"source_date":"2026-03-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:12","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:emil-d-kakkis-m-d-ph-d","object_label":null,"object_source_name_forms":[],"value":"Emil D. Kakkis, M.D., Ph.D.: President, Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Emil D. Kakkis, M.D., Ph.D.: President, Chief Executive Officer and Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000174","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-12T18:07:23.013453+00:00","locator":null}],"source_date":"2026-03-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:13","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:matthew-k-fust-rare","object_label":null,"object_source_name_forms":[],"value":"Matthew K. Fust: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Matthew K. Fust: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2014-01-01","valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:3","source_type":"sec_proxy","title":"DEF 14A lrare2026_def14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-02T01:57:54.019734+00:00","locator":null}],"source_date":"2026-03-27T00:00:00+00:00","effective_from":"2014-01-01","effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:14","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-narachi-rare","object_label":null,"object_source_name_forms":[],"value":"Michael Narachi: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Michael Narachi: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:3","source_type":"sec_proxy","title":"DEF 14A lrare2026_def14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-02T01:57:54.019734+00:00","locator":null}],"source_date":"2026-03-27T00:00:00+00:00","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:15","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:shehnaaz-suliman-rare","object_label":null,"object_source_name_forms":[],"value":"Shehnaaz Suliman: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Shehnaaz Suliman: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:3","source_type":"sec_proxy","title":"DEF 14A lrare2026_def14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-02T01:57:54.019734+00:00","locator":null}],"source_date":"2026-03-27T00:00:00+00:00","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:16","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:shehnaaz-suliman-m-d","object_label":null,"object_source_name_forms":[],"value":"Shehnaaz Suliman, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Shehnaaz Suliman, M.D.: Director","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000174","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-12T18:07:23.013453+00:00","locator":null}],"source_date":"2026-03-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:17","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:dennis-huang","object_label":null,"object_source_name_forms":[],"value":"Dennis Huang: Chief Technical Operations Officer and Gene Therapy and Executive Vice President","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Dennis Huang: Chief Technical Operations Officer and Gene Therapy and Executive Vice President","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000174","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-12T18:07:23.013453+00:00","locator":null}],"source_date":"2026-03-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:18","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:emil-d-kakkis-m-d-ph-d","object_label":null,"object_source_name_forms":[],"value":"Emil D. Kakkis, M.D., Ph.D.: President and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Emil D. Kakkis, M.D., Ph.D.: President and Chief Executive Officer","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000174","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-12T18:07:23.013453+00:00","locator":null}],"source_date":"2026-03-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:19","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:eric-crombez-m-d","object_label":null,"object_source_name_forms":[],"value":"Eric Crombez, M.D.: Chief Medical Officer and Executive Vice President","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Eric Crombez, M.D.: Chief Medical Officer and Executive Vice President","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000174","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-12T18:07:23.013453+00:00","locator":null}],"source_date":"2026-03-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:20","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:erik-harris","object_label":null,"object_source_name_forms":[],"value":"Erik Harris: Chief Commercial Officer and Executive Vice President","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Erik Harris: Chief Commercial Officer and Executive Vice President","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000174","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-12T18:07:23.013453+00:00","locator":null}],"source_date":"2026-03-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:21","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:howard-horn","object_label":null,"object_source_name_forms":[],"value":"Howard Horn: Chief Financial Officer, Corporate Strategy and Executive Vice President","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Howard Horn: Chief Financial Officer, Corporate Strategy and Executive Vice President","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000174","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-12T18:07:23.013453+00:00","locator":null}],"source_date":"2026-03-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:22","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:john-r-pinion-ii","object_label":null,"object_source_name_forms":[],"value":"John R. Pinion II: Chief Quality Officer and Executive Vice President of Translational Sciences","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"John R. Pinion II: Chief Quality Officer and Executive Vice President of Translational Sciences","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000174","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-12T18:07:23.013453+00:00","locator":null}],"source_date":"2026-03-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:23","subject_id":"alpha:company:0d171594-5056-4796-a2e8-c666d6937243","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:karah-parschauer","object_label":null,"object_source_name_forms":[],"value":"Karah Parschauer: Chief Legal Officer & Corporate Affairs and Executive Vice President","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Karah Parschauer: Chief Legal Officer & Corporate Affairs and Executive Vice President","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-28T14:40:03.785268+00:00","sources":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000174","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-12T18:07:23.013453+00:00","locator":null}],"source_date":"2026-03-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-09-28T14:40:03.785268+00:00","reviewed_at":"2026-09-28T14:40:03.785268+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"}],"evidence":[{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/ultragenyx-pharmaceutical-inc","source_date":null,"retrieved_at":"2026-09-28T14:40:03.785268+00:00","locator":null},{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000174","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-12T18:07:23.013453+00:00","locator":null},{"id":"alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:3","source_type":"sec_proxy","title":"DEF 14A lrare2026_def14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_date":"2026-03-27T00:00:00+00:00","retrieved_at":"2026-09-02T01:57:54.019734+00:00","locator":null}],"coverage":{"identity":"PUBLISHED","business":"PUBLISHED","leadership":"PUBLISHED","board_and_committees":"PUBLISHED","governance":"NOT_ASSERTED","financials":"NOT_ASSERTED","workforce":"NOT_ASSERTED","ownership":"NOT_ASSERTED","ratings":"NOT_PUBLISHED","market_and_index_context":"PUBLISHED"},"representation_version":"alpha-governance-record-v2","role_modules":[],"attention":[],"committee_data":[]}